首页> 外文期刊>Journal of cardiac surgery. >Minimally invasive single‐vessel left internal mammary to left anterior descending artery bypass grafting improves outcomes over conventional sternotomy: A single‐institution retrospective cohort study
【24h】

Minimally invasive single‐vessel left internal mammary to left anterior descending artery bypass grafting improves outcomes over conventional sternotomy: A single‐institution retrospective cohort study

机译:微创单血管留下内部乳腺至左侧后期下降动脉旁路移植改善了传统胸骨切开术的结果:一个单一的回顾队列队列研究

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Background: Coronary artery bypass grafting (CABG) can be performed through a variety of approaches. Minimally‐invasive CABG (MICABG) may reduce perioperative morbidity. Previous results demonstrate improved perioperative outcomes; however, adoption has been limited. Methods: The Society of Thoracic Surgeons (STS) database and electronic medical record at a single institution were reviewed for isolated left internal mammary to left anterior descending artery (LIMA‐LAD) bypass procedures performed between 2011 and 2018. Patients were grouped on the basis of operative approach, comparing sternotomy to non‐sternotomy (minimally‐invasive). Patient characteristics, perioperative variables, and short‐ and long‐term outcomes were compared. Primary outcomes included mortality and major adverse cardiac events (MACE). Secondary outcomes were morbidity. Results: A total of 42 MICABG and 54 conventional LIMA‐LAD procedures were performed with 95.2% of MICABG procedures performed by two surgeons. MICABG were more often elective (83.3 vs 38.9%, P ??.001). STS risk scores predicted equitable mortality and morbidity for MICABG dependent on operative indication. MICABG was associated with fewer pulmonary complications (0.0 vs 11.1%, P ?=?.033), in‐hospital events (11.9 vs 37.0%, P ?=?.005), and shorter intensive care unit (34.1 vs 66.0?hours, P ?=?.022) and total length of stay (3.7 vs 6.5 days, P ?=?.002). There were no observed strokes, myocardial infarctions, or reoperations. MICABG patients demonstrated reduced thirty‐day mortality (0.0 vs 10.9%, P ?=?.036) and improved Kaplan‐Meier 5‐year (95.2 vs 77.9%, P ?=?.016) and MACE‐free survival (89.2 vs 63.9%, P ?=?.010). Conclusions: Minimally‐invasive LIMA‐LAD CABG demonstrates improved early postoperative morbidity and a long‐term mortality benefit. In select patients, minimally‐invasive approaches to single‐vessel grafting may be beneficial when performed by experienced surgeons in the elective setting.
机译:摘要背景:冠状动脉旁路移植(CABG)可以通过各种方法进行。微创CABG(MICABG)可能会降低围手术期的发病率。以前的结果表明了改善的围手术期结果;但是,采用受到限制。方法:在2011年和2018年间左侧下降动脉(Lima-Lad)旁路程序进行孤立的左内部乳房(STS)数据库(STS)数据库(STS)数据库和电子医疗记录的临床外科医生和电子医疗记录。操作方法,将胸骨切开术与非胸骨切开术(微创)进行比较。比较患者特征,围手术期变量和短期和长期结果。主要结果包括死亡率和主要不良心脏事件(MACE)。二次结果是发病率。结果:共有42个MicaBG和54个常规的L​​ima-LAD程序进行,通过两个外科医生进行的95.2%的MicaBG程序进行。 Micabg更频繁地供电(83.3 Vs 38.9%,p?001)。 STS风险评分预测米宝依赖于手术指示的公平死亡率和发病率。 Micabg与较少的肺部并发症有关(0.0 Vs 11.1%,p?= 033),内部活动(11.9 Vs 37.0%,p?= 005)和更短的重症监护单元(34.1 vs 66.0?小时,p?=?022)和总住宿时间(3.7 Vs 6.5天,p?= 002)。没有观察到的中风,心肌梗塞或重新进步。 Micabg患者展示了30天死亡率减少(0.0 vs 10.9%,p?= 036),并改善了Kaplan-Meier 5年(95.2 vs 77.9%,P?= 016)和免费生存(89.2 Vs 63.9%,p?= 010)。结论:微创利马LAD CABG显示出改善术后发病率和长期死亡效益。在选择患者中,当在选修设定中经验丰富的外科医生进行时,单血管移植的微创方法可能是有益的。

著录项

  • 来源
    《Journal of cardiac surgery.》 |2019年第9期|共8页
  • 作者单位

    Department of Surgery Division of Cardiothoracic SurgeryMedical College of WisconsinMilwaukee WI;

    Department of Surgery Division of Cardiothoracic SurgeryMedical College of WisconsinMilwaukee WI;

    Department of Surgery Division of Cardiothoracic SurgeryMedical College of WisconsinMilwaukee WI;

    Department of Surgery Division of Cardiothoracic SurgeryMedical College of WisconsinMilwaukee WI;

    Department of Surgery Division of Cardiothoracic SurgeryMedical College of WisconsinMilwaukee WI;

    Department of Surgery Division of Cardiothoracic SurgeryMedical College of WisconsinMilwaukee WI;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 心脏血管和淋巴系外科学;
  • 关键词

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号